Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma

被引：0
作者：
Yang Dong
Wei-ming Ma
Wen Yang
Lin Hao
Shao-qi Zhang
Kun Fang
Chun-hui Hu
Qian-jin Zhang
Zhen-duo Shi
Wen-da Zhang
Tao Fan
Tian Xia
Cong-hui Han
机构：
[1] Xuzhou Central Hospital,Department of Urology
[2] Medical College of Soochow University,Department of Nephrology
[3] The First Affiliated Hospital of Shandong Academy of Medical Sciences,Department of Urology
[4] Nanjing University of Traditional Chinese Medicine,undefined
[5] The Third Affiliated Hospital of Soochow University,undefined
[6] Jiangsu Normal University,undefined
来源：
BMC Cancer | / 21卷
关键词：
Clear cell renal cell carcinoma; Biomarker; Prognostic value; Complement component 3; Fibronectin 1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 510 条
  • [1] Ljungberg B(2015)EAU guidelines on renal cell carcinoma: 2014 update Eur Urol 67 913-924
  • [2] Bensalah K(2019)clinicalguidelines@esmo.org EGCEa: renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-updagger Ann Oncol 30 706-720
  • [3] Canfield S(2011)The epidemiology of renal cell carcinoma Eur Urol 60 615-621
  • [4] Dabestani S(2015)Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity Eur Urol 67 85-97
  • [5] Hofmann F(2016)Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma Mol Cancer 15 10-137
  • [6] Hora M(2018)Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma Cancer Treat Rev 70 127-366
  • [7] Kuczyk MA(2020)Combination therapy in metastatic renal cell carcinoma: Back to the future? Semin Oncol 47 361-214
  • [8] Lam T(2021)Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma Nat Rev Clin Oncol 18 199-353
  • [9] Marconi L(2015)The PI3K/AKT pathway and renal cell carcinoma J Genet Genomics 42 343-759
  • [10] Merseburger AS(2012)BAP1 loss defines a new class of renal cell carcinoma Nat Genet 44 751-4810
12345678910